Unknown NA INTERVENTIONAL 2-arm NCT05841836

The Safety and Efficacy of the Suture-Mediated Closure System

A Prospective, Multi-center, Randomized Controlled, Non-inferiority Clinical Trial of the Safety and Efficacy of the Suture-Mediated Closure System for Percutaneous Closure of the Common Femoral Artery Puncture Site

Sponsor: Zhejiang Zylox Medical Device Co., Ltd.

Conditions Arterial Puncture Peripheral Arterial Disease

Interventions Perclose ProGlide Suture-Mediated Closure System the Suture-Mediated Closure System

Updated 4 times since 2023 Last updated: Apr 23, 2023 Started: Oct 26, 2022 Primary completion: May 30, 2023 Completion: Jul 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05841836, this NA trial focuses on Arterial Puncture and Peripheral Arterial Disease and remains ongoing. Sponsored by Zhejiang Zylox Medical Device Co., Ltd., it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

May 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhejiang Zylox Medical Device Co., Ltd.

Data source: Zhejiang Zylox Medical Device Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China